Natural Course of Gastric Subepithelial Tumors

Gastric subepithelial tumors (SETs) are being increasingly detected owing to the widespread use of endoscopy. These lesions vary in etiology, with gastrointestinal stromal tumors (GISTs), leiomyomas, and ectopic pancreas among the most common types. Because some gastric SETs, such as GISTs, have mal...

Full description

Saved in:
Bibliographic Details
Published inThe Korean journal of helicobacter and upper gastrointestinal research Vol. 25; no. 3; pp. 224 - 233
Main Authors Kim, Ji Yoon, Kang, Seung Joo
Format Journal Article
LanguageEnglish
Published 대한상부위장관ㆍ헬리코박터학회 10.09.2025
Subjects
Online AccessGet full text
ISSN1738-3331
2671-826X
DOI10.7704/kjhugr.2025.0039

Cover

More Information
Summary:Gastric subepithelial tumors (SETs) are being increasingly detected owing to the widespread use of endoscopy. These lesions vary in etiology, with gastrointestinal stromal tumors (GISTs), leiomyomas, and ectopic pancreas among the most common types. Because some gastric SETs, such as GISTs, have malignant potential, the development of an appropriate management plan is crucial. However, the management of gastric SETs remains challenging owing to the limited information available regarding their natural courses. In this review, currently available studies were analyzed to summarize the existing evidence on the natural history and progression of gastric SETs based on initial tumor sizes and endoscopic ultrasound (EUS) features, highlighting that most small SETs (<30 mm in size) remain stable over time. Larger initial tumor sizes and irregular tumor margins, determined during EUS, are key risk factors for tumor progression. Other factors, such as older patient age, tumor location, and certain echogenic characteristics, have also been suggested to be associated with tumor progression. Additionally, tumor doubling times provide valuable information for distinguishing aggressive tumors, with high-risk GISTs demonstrating rapid growth. Surveillance strategies should be individualized based on these factors. Regular endoscopic or EUS follow-up is generally recommended for small asymptomatic SETs, with closer monitoring of lesions exhibiting high-risk features.
ISSN:1738-3331
2671-826X
DOI:10.7704/kjhugr.2025.0039